Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar tkaikobad (< 20) Submitted: 5/23/2009 12:34:31 PM : Underperform Start Price: $6.35 SCR Score: +16.76

to much volatility

Report this Post Reply

Featured Broker Partners


Advertisement